Drugmakers Suspend Autoimmune Trials After Fatalities
Trials by Novartis and Bristol Myers have been paused, prompting investigations into why a promising autoimmune treatment has become risky. The halt highlights concerns over safety issues related to the therapy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)